Presentation TCT 2012 TCT-22. Combination of High Wall Shear Stress, Plaque Burden, and Plaque Phenotype has Incremental Value for Prediction of Increased Plaque Vulnerability in Patients with... Presenter: Michel Corban October 23, 2012
Presentation TCT 2012 Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3) Presenter: Ian Meredith October 23, 2012
Presentation TCT 2012 TCT-86. Results of the Amplatzer Cardiac Plug European Multicenter Prospective Observational Study Presenter: Jai-Wun Park October 23, 2012
Presentation TCT 2012 OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies Presenter: Shiro Uemura October 23, 2012
Presentation TCT 2012 When Should the MitraClip Be Considered for Front-Line Therapy of Degenerative MR? Presenter: Michael Rinaldi October 23, 2012
Presentation TCT 2012 Importance of Sustained Patency and the Role of DES for Infrapopliteal Intervention Presenter: Robert Lookstein October 23, 2012
Presentation TCT 2012 TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity Presenter: Joseph Jakubowski October 23, 2012
Presentation TCT 2012 TCT-30. Clinical Outcomes Following Radial Versus Femoral Artery Access in Primary or Rescue Percutaneous Coronary Intervention in Scotland: Retrospective Cohort Study of 4534... Presenter: Colin Berry October 23, 2012
Presentation TCT 2012 What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights Presenter: Patrick Serruys October 23, 2012
Presentation TCT 2012 State-of-the-Field Keynote: Technical and Biological Challenges for Future DCB Development Presenter: Juan Granada October 23, 2012